$CDTX Cidara Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Cidara Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Cidara Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Cidara Therapeutics, Inc. for free.

CIK Number: 0001610618
IRS Number: 461537286
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CDTX
Company Address: 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO 92121
Phone number: 858-752-6170
Former name: K2 THERAPEUTICS, INC., date of change: 2014-06-11

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. Its product pipeline includes Rezafungin and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Market Capitalization: $167.56M
Prev close: $9.60
Average Daily Volume: 51,160
Days Low: $9.57
Year Low: $8.65
Year High: $15.91

Cidara Therapeutics, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Abdollahian NeilChief Business Officer51,248491,981shares bought: 43,400 / shares sold: -11,924 STRONG BUYMar 23 20202 months ago
Daruwala PaulChief Operating Officer53,532513,907shares bought: 30,600 / shares sold: -7,875 STRONG BUYMar 23 20202 months ago
Levine James E.Chief Financial Officer61,891594,154shares bought: 91,891 / shares sold: 0 STRONG BUYMar 23 20202 months ago
Oien JessicaGeneral Counsel & Secretary6,96566,864shares bought: 8,800 / shares sold: -1,835 STRONG BUYMar 23 20202 months ago
Sandison TaylorChief Medical Officer67,216645,274shares bought: 55,609 / shares sold: 0 STRONG BUYMar 23 20202 months ago
Stein JeffreyPresident & CEO293,8782,821,229shares bought: 422,456 / shares sold: -30,578 STRONG BUYMar 23 20202 months ago

View all Cidara Therapeutics, Inc. insiders.

Cidara Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 23 2020CDTXCidara Therapeutic ...Abdollahian NeilChief Business Offi ...Option ExerciseA1.98115,000227,700115,000
Mar 23 2020CDTXCidara Therapeutic ...Sandison TaylorChief Medical Offic ...Option ExerciseA1.98145,000287,100145,000
Mar 23 2020CDTXCidara Therapeutic ...Daruwala PaulChief Operating Off ...Option ExerciseA1.9890,000178,20090,000
Mar 23 2020CDTXCidara Therapeutic ...Oien JessicaGeneral Counsel & S ...Option ExerciseA1.9890,000178,20090,000
Mar 23 2020CDTXCidara Therapeutic ...Stein JeffreyPresident & CEOOption ExerciseA1.98330,000653,400330,000
Mar 23 2020CDTXCidara Therapeutic ...Levine James E.Chief Financial Off ...Option ExerciseM1.98110,000217,800110,000
Mar 23 2020CDTXCidara Therapeutic ...Levine James E.Chief Financial Off ...GrantA0.0025,000061,89136.9 K to 61.9 K (+67.77 %)
Feb 11 2020CDTXCidara Therapeutic ...Sandison TaylorChief Medical Offic ...Option ExerciseX2.516,11515,3490
Feb 11 2020CDTXCidara Therapeutic ...Sandison TaylorChief Medical Offic ...Option ExerciseX2.514,59411,5310
Feb 11 2020CDTXCidara Therapeutic ...Sandison TaylorChief Medical Offic ...BuyX2.516,11515,34973,33167.2 K to 73.3 K (+9.10 %)
Feb 11 2020CDTXCidara Therapeutic ...Sandison TaylorChief Medical Offic ...BuyX2.514,59411,53167,21662.6 K to 67.2 K (+7.34 %)
Jan 30 2020CDTXCidara Therapeutic ...Stein JeffreyPresident & CEOOption ExerciseX2.5132,28381,0300
Jan 30 2020CDTXCidara Therapeutic ...Stein JeffreyPresident & CEOOption ExerciseX2.517,55818,9710
Jan 30 2020CDTXCidara Therapeutic ...Stein JeffreyPresident & CEOBuyX2.5132,28381,030257,902225.6 K to 257.9 K (+14.31 %)
Jan 30 2020CDTXCidara Therapeutic ...Stein JeffreyPresident & CEOBuyX2.517,55818,971293,878286.3 K to 293.9 K (+2.64 %)

View all Cidara Therapeutics, Inc. insider transactions.